首页> 外国专利> Pharmaceutical formulation comprising Pleconaril

Pharmaceutical formulation comprising Pleconaril

机译:包含培康那尔的药物制剂

摘要

Refers to a Pharmaceutical composition in the form of Pleconaril Solution comprising: (a); (b) a Solvent comprising a triglyceride prepared from a mixture of saturated fatty acids, such as: (i) Capric acid in an amount of 30% to 40% in weight, caprylic acid (ii) in an amount of 50% 65% by weight, and (iii) Fatty Acids with a chain length of C6C12 and C14 in an amount of 5%; (c) a corticosteroid such as dexamethasone, Mometasone furoate, budesonide, among others; (d) as a decongestant oxymetazoline, pseudoephedrine, Naphazoline, among others); and an aqueous Carrier comprising microcrystalline Cellulose and carboxialquilcelulosa of Alkali metal; and (f) other active Agent such as an antihistamine, anti-inflammatory,Expectorant, among others. Said composition is useful as an aerosol for Inhalation in the treatment of respiratory diseases
机译:指Pleconaril溶液形式的药物组合物,包括:(a); (b)包含甘油三酸酯的溶剂,该甘油三酸酯由饱和脂肪酸的混合物制备,例如:(i)30%至40%重量的癸酸,50%65%的辛酸(ii) (iii)链长为C6C12和C14的脂肪酸,含量为5%; (c)皮质类固醇,例如地塞米松,糠酸莫米松,布地奈德等; (d)作为充血剂羟甲唑啉,伪麻黄碱,萘甲唑啉等);水性载体,其包含微晶纤维素和碱金属的羧碳纤维素; (f)其他活性剂,例如抗组胺药,抗炎药,Expectorant等。所述组合物可用作吸入剂以治疗呼吸系统疾病

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号